

Publisher: John Wiley & Sons Inc
E-ISSN: 1349-7006|109|2|317-329
ISSN: 1347-9032
Source: Cancer Science, Vol.109, Iss.2, 2018-02, pp. : 317-329
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma
Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. :


Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. :



